Dr Brian Burlinson

Dr Burlinson was appointed as a member in April 2003. He has a great deal of experience in the development of new assays important to the COM's recommended strategy for testing (for example the COMET and UDS assays). He has been involved in collaborative work with other laboratories in EU and wider. He is interested in communication of complex risk assessment issues to the general public.

Declaration Of Interests

Personal Interest

Non-Personal Interest

Company

Interest

Company

Interest

Huntingdon Life

Sciences

Salary

Employee

Share Option Holder

NONE